What Does the National Practitioner Data Bank (NPDB) Consider a "Reportable" Adverse Clinical Privileges Action?
Reportability of adverse clinical privileges actions often hinges on one term: "professional review action." Here is what that means in practice — and what the NPDB's own guidance does not spell out
A Former NPDB Insider on What the Guidebook Doesn't Clearly Explain About Reportable Adverse Clinical Privileges Actions
This is policy guidance, not legal advice.
Applies to: Private sector hospitals and health systems. Reporting requirements for federal facilities differ.
Why Can the NPDB's Own Guidance Be So Dense and Hard to Follow at Times?
Let me let you in on a little secret. The National Practitioner Data Bank ("NPDB") has very limited knowledge about hospitals and healthcare settings — outside of what hospitals are required to query and report to them.
During my 7-year tenure at the NPDB, I was the only person on staff with a credentialing and privileging background. The only one who had worked in hospital administration and quality. The only one who had actually sat in credentialing committee meetings and Medical Executive Committee ("MEC") meetings. Most colleagues came from other federal agencies or brought policy and legal expertise — skilled at interpreting legislation, but without hands-on experience inside a hospital system.
That gap — combined with the red tape that constrains anything a federal agency puts in writing — is exactly why NPDB guidance can be so hard to follow. And while I worked to improve that clarity from the inside, federal agencies must use the terms as they are defined in the authorizing legislation — there is little room to substitute plain language in official guidance.
There is another layer to it as well. The NPDB is bound to the legislative and regulatory language that governs them. Some of those terms are almost foreign in hospital settings — but the NPDB has no choice but to use them, because they come directly from the federal statute that created the NPDB. So let me translate.
Determining If an Adverse Clinical Privileges Action Is Reportable
There are two primary scenarios under which a adverse clinical privileges action may be reportable to the NPDB: actions that last longer than 30 days, and certain actions that occur while a physician is under investigation.
We will unpack the investigations piece in a separate blog post. For now, let's focus on adverse clinical privileges actions lasting longer than 30 days — and one key term that determines whether such an action meets the legal definition of "reportable."
But first for reference, here is how it is described in the NPDB Guidebook, Chapter E (October 2018 update):
"Hospitals and other health care entities must report adverse clinical privileges actions to the NPDB that meet NPDB reporting criteria — that is, any professional review action that adversely affects the clinical privileges of a physician or dentist for a period of more than 30 days or the acceptance of the surrender of clinical privileges, or any restriction of such privileges by a physician or dentist, (1) while the physician or dentist is under investigation by a health care entity relating to possible incompetence or improper professional conduct, or (2) in return for not conducting such an investigation or proceeding."
NPDB Guidebook, Chapter E: https://www.npdb.hrsa.gov/guidebook/EClinicalPrivileges.jsp
"Professional Review Action" — Where Legal Arguments on Reportability Are Often Made
There it is. That term. "Professional review action."
I never heard it once while working on the hospital side. Not once. But it carries enormous weight — it is the legal hinge on which reportability often turns, and it is a term the NPDB relies on when determining whether a adverse clinical privileges action is required to be reported.
So what is a professional review action? In hospital terms: usually, a formal action taken by your Medical Executive Committee ("MEC") and/or Governing Body, taken to protect patients, that provides the practitioner with the opportunity for a hearing. That will generally meet the regulatory definition. Assuming your MEC is compliant with The Joint Commission ("TJC") standards.
But let's look at the exact statutory language — linked on the NPDB's own website — rather than take my word for it.
The governing legislation, 42 U.S.C. §11112, defines the standards a professional review action must meet:
(a) In general — a professional review action must be taken —
(1) in the reasonable belief that the action was in the furtherance of quality health care,
(2) after a reasonable effort to obtain the facts of the matter,
(3) after adequate notice and hearing procedures are afforded to the physician involved or after such other procedures as are fair to the physician under the circumstances, and
(4) in the reasonable belief that the action was warranted by the facts known after such reasonable effort to obtain facts and after meeting the requirement of paragraph (3).
Full text: 42 U.S.C. §11112: https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section11112&num=0&edition=prelim and at
https://www.govinfo.gov/content/pkg/USCODE-2011-title42/html/USCODE-2011-title42-chap117.htm
Breaking It Down
Did your MEC and/or Governing Body take a formalized action — suspension, restriction, reduction of privileges — against a practitioner, following your bylaws and TJC requirements, and affording that practitioner the opportunity for a hearing?
And did that action remain in effect for more than 30 days?
Was it a result of an issue that could potentially impact patient safety?
If yes to all three: this is the point where most reportability determinations turn — and in many cases, you have a reportable event.
Reviewing the exact documentation matters enormously. MEC minutes, bylaws language, FPPE records, hearing notices — these are the materials the NPDB's own policy team reviews when a practitioner disputes a report. Understanding the full legislation, and how it has been applied in prior cases, is essential. This is not a determination to make casually or without expertise.
A word of caution before moving on. Whether an action qualifies as a "professional review action" is not the only factor in determining reportability of an adverse clinical privileges action — but it is the primary one, and the one where a lot of the legal and policy debate lives. Reportability is a fact-specific determination, and the full picture matters. It is always advisable to run the specifics of a reportable action — or a hypothetical scenario you are working through — by an expert in both the policy and the operational realities of how these determinations get made. That is exactly what I do.
What the NPDB Won't Tell You Beforehand
The NPDB's public guidance on "professional review action" is intentionally general. They are not going to walk a hospital through how much interpretive weight their own bylaws and documentation carry in a reportability determination — or how much deference the NPDB gives to a hospital's own characterization of an action. That level of specificity simply does not appear in the Guidebook.
How do I know? Because I was there — and because I have seen firsthand how those determinations get made when a report gets disputed.
Do Healthcare Systems Benefit from Reporting?
Yes — and it is written directly into the statute.
Properly conducted professional review actions carry significant legal protections under 42 U.S.C. §11111. When the standards of §11112(a) are met, the professional review body, its members, and anyone who participates in or assists with the action are shielded from damages liability under federal and state law. Peer reviewers who provide information to the body in good faith are protected as well.
Full text: 42 U.S.C. §11111: https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section11111&num=0&edition=prelim and at
Reporting is not just a compliance obligation. Done correctly, it is a legal shield.
Not Sure Where Your Situation Falls?
Reportability determinations are rarely black and white. The statutory framework sets the standard, but the facts of each situation — your documentation, your bylaws language, how the action was classified — determine the outcome. That is where interpretation matters more than the text alone, and where having someone who has sat on both sides of this process makes a difference.
I work with legal counsel, healthcare systems, and physicians navigating exactly these questions — whether you are evaluating a current action, responding to a disputed report, or working through a hypothetical scenario.
Have Questions?
Claudia M. Rausch
The rules governing licensed practitioners, hospitals, and federal reporting were not designed to be legible to outsiders. If you are navigating a situation and need help understanding what the rules actually require — this is where to start. You do not need to already understand the system to reach out.
Schedule a Confidential Consultation →Prefer to reach out first? Submit a confidential inquiry →
Next post: Investigations. How the NPDB defines the term, why their definition is almost certainly broader than anything written in your bylaws, and what that means for your reporting obligations.
